C4 Therapeutics, Inc. (CCCC) dividend history
CCCCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3018% above fair value
$2.76−0.01 (-0.36%)
Close on Nov 13, 2026Market cap $339.55MP/E –Yield –
Dividends
C4 Therapeutics has not reported a dividend
No dividend per share appears in C4 Therapeutics's annual filings since fiscal 2018.
See a number that looks wrong?